An MRI contrast agent that can pass through the blood-brain barrier will allow doctors to detect deadly brain tumors called gliomas earlier, say researchers. This ability opens the door to make this fatal cancer treatable.
An MRI contrast agent that can pass through the blood-brain barrier will allow doctors to detect deadly brain tumors called gliomas earlier, say researchers. This ability opens the door to make this fatal cancer treatable.